Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

P0908FGF-23, MBD AND INFLAMMATION IN CKD

View through CrossRef
Abstract Background and Aims Systemic inflammation, as well as Mineral and Bone Disease, are seen to be inherent complications of CKD, tightly related to cardio-vascular disease, protein-energy wasting and general mortality. It remains an actual problem to study relation between systemic inflammation and CKD-MBD. The aim of the study was to evaluate serum concentrations of c-terminal FGF-23 as an early marker of CKD MBD, Il-1 β, Il-6, Il-8 as inflammatory markers, and to establish relationships between FGF-23 and IL-1 β, Il-6, Il-8. Method The study involved 106 patients with CKD stages from 1 to 4, 47 women (44%) and 59 men (56%) aged from 35 to 72, mean (49.6± 13.9) years. The C-terminal FGF-23 fragment was determined using a set of reagents for the enzyme immunoassay «Biomedica». Concentration of IL-1β, IL-6 and IL-8 was determined using an assay «Vector BEST». The glomerular filtration rate (GFR) was calculated using the CKD EPI formula (KDIGO 2012). Results A progressive growth in FGF-23 levels was observed simultaneously with GFR decrease in patients with CKD. IL-1 concentration increased from CKD stage 1 ((12.64±4.30) pg/ml) to 4 ((32.06±7.86) pg/ml) (p <0.05) accordingly GFR fall, as well as the level of IL-6 ((7.25±2.14) pg/ml to (46.27±10,06)pg/ml) and Il-8 ((9.39±1.62) pg/ml to (33.00±9.17)pg/ml). The existence of a strong direct association (r = 0.84, p <0.05) between the level of Il-6 and FGF-23 in CKD stages 1-4 was established. IL-1 and Il-8 were found to have a medium strength assotiation (r=0.45, p <0.05 and r=0.57, p <0.05, accordingly) with FGF-23 concentration in patients with CKD stages 2-4. Conclusion The increase in the concentration of inflammatory factors along with progression of chronic renal failure was revealed. The existence of a strong link between the level of IL-6 and the C-terminal fragment of FGF-23 in CKD was established. Finding out the issue of the primary stimulation factor of FGF-23 production in CKD requires further research.
Title: P0908FGF-23, MBD AND INFLAMMATION IN CKD
Description:
Abstract Background and Aims Systemic inflammation, as well as Mineral and Bone Disease, are seen to be inherent complications of CKD, tightly related to cardio-vascular disease, protein-energy wasting and general mortality.
It remains an actual problem to study relation between systemic inflammation and CKD-MBD.
The aim of the study was to evaluate serum concentrations of c-terminal FGF-23 as an early marker of CKD MBD, Il-1 β, Il-6, Il-8 as inflammatory markers, and to establish relationships between FGF-23 and IL-1 β, Il-6, Il-8.
Method The study involved 106 patients with CKD stages from 1 to 4, 47 women (44%) and 59 men (56%) aged from 35 to 72, mean (49.
6± 13.
9) years.
The C-terminal FGF-23 fragment was determined using a set of reagents for the enzyme immunoassay «Biomedica».
Concentration of IL-1β, IL-6 and IL-8 was determined using an assay «Vector BEST».
The glomerular filtration rate (GFR) was calculated using the CKD EPI formula (KDIGO 2012).
Results A progressive growth in FGF-23 levels was observed simultaneously with GFR decrease in patients with CKD.
IL-1 concentration increased from CKD stage 1 ((12.
64±4.
30) pg/ml) to 4 ((32.
06±7.
86) pg/ml) (p <0.
05) accordingly GFR fall, as well as the level of IL-6 ((7.
25±2.
14) pg/ml to (46.
27±10,06)pg/ml) and Il-8 ((9.
39±1.
62) pg/ml to (33.
00±9.
17)pg/ml).
The existence of a strong direct association (r = 0.
84, p <0.
05) between the level of Il-6 and FGF-23 in CKD stages 1-4 was established.
IL-1 and Il-8 were found to have a medium strength assotiation (r=0.
45, p <0.
05 and r=0.
57, p <0.
05, accordingly) with FGF-23 concentration in patients with CKD stages 2-4.
Conclusion The increase in the concentration of inflammatory factors along with progression of chronic renal failure was revealed.
The existence of a strong link between the level of IL-6 and the C-terminal fragment of FGF-23 in CKD was established.
Finding out the issue of the primary stimulation factor of FGF-23 production in CKD requires further research.

Related Results

P0686THE CIRCADIAN RHYTHM IN CKD PATIENTS
P0686THE CIRCADIAN RHYTHM IN CKD PATIENTS
Abstract Background and Aims It is common to see that patients with chronic kidney disease CKD are complaint with sleep disorder...
Adherence to dietary recommendations and chronic kidney disease : insights into disease onset and progression
Adherence to dietary recommendations and chronic kidney disease : insights into disease onset and progression
<p dir="ltr">Background: CKD is becoming a major global health concern, marked by a gradual, permanent decline in kidney function, constrained treatment possibilities, and ri...
Adherence to dietary recommendations and chronic kidney disease : insights into disease onset and progression
Adherence to dietary recommendations and chronic kidney disease : insights into disease onset and progression
<p dir="ltr">Background: CKD is becoming a major global health concern, marked by a gradual, permanent decline in kidney function, constrained treatment possibilities, and ri...
Adherence to dietary recommendations and chronic kidney disease : insights into disease onset and progression
Adherence to dietary recommendations and chronic kidney disease : insights into disease onset and progression
<p dir="ltr">Background: CKD is becoming a major global health concern, marked by a gradual, permanent decline in kidney function, constrained treatment possibilities, and ri...
Diagnosis and Management of Marchiafava-Bignami Disease, a Rare Neurological Complication of Long-term Alcohol Abuse
Diagnosis and Management of Marchiafava-Bignami Disease, a Rare Neurological Complication of Long-term Alcohol Abuse
Marchiafava Bignami disease (MBD) is a neurological disorder characterized by myelin degeneration and tissue necrosis within the central nervous system. This condition predominantl...
Risk Factors of Metabolic Bone Disease in Bronchopulmonary Dysplasia Premature Infants With Gestational Age Less Than 32 Weeks
Risk Factors of Metabolic Bone Disease in Bronchopulmonary Dysplasia Premature Infants With Gestational Age Less Than 32 Weeks
Abstract BackgroundMetabolic bone disease (MBD) is a complication of multifactorial aetiology in preterm infants. Several risk factors have been identified in general. Bron...
#990 Association between frailty and chronic kidney disease: findings from CHARLS
#990 Association between frailty and chronic kidney disease: findings from CHARLS
Abstract Background and Aims Frailty is a complex age-related clinical condition characterized by a decline in physiological cap...

Back to Top